BVI Medical, a Waltham, MA-based global ophthalmic device company, completed a $1 Billion in strategic capital raise in partnership with TPG.
This investment, which fully refinances BVI’s existing debt and adds new equity from both TPG and new investors, strengthens the company’s financial position as it looks to accelerate product innovation and expand its global footprint.
The raise positions the company for several new product launches and scaling of operations to meet rising demand globally. The organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of distributors.
Led by Shervin Korangy, President and CEO, BVI is a diversified global ophthalmic device company aiming to deliver solutions and innovation for advancing eye surgery and improving patients’ vision.
This financing followed a period of accelerated growth for BVI, during which the company has grown its portfolio of product offerings and built one of the most robust product pipelines in the industry.
Most recently, BVI expanded its IOL manufacturing in Europe to meet growing global demand, introduced new product lines such as SERENITY and SERENITY Toric premium monofocal IOLs, and strengthened its market position through strategic acquisitions.
